» Articles » PMID: 38124795

SATORI: Amplification-free Digital RNA Detection Method for the Diagnosis of Viral Infections

Overview
Specialty Biophysics
Date 2023 Dec 21
PMID 38124795
Authors
Affiliations
Soon will be listed here.
Abstract

With the recent global outbreak of COVID-19, there is an urgent need to establish a versatile diagnostic method for viral infections. Gene amplification test or antigen test are widely used to diagnose viral infections; however, these methods generally have technical drawbacks either in terms of sensitivity, accuracy, or throughput. To address this issue, we recently developed an amplification-free digital RNA detection method (SATORI), which can identify and detect viral genes at the single-molecule level in approximately 9 min, satisfying almost all detection performance requirements for the diagnosis of viral infections. In addition, we also developed practical platforms for SATORI, such as an automated platform (opn-SATORI) and a low-cost compact fluorescence imaging system (COWFISH), with the aim of application in clinical settings. Our latest technologies can be inherently applied to diagnose a variety of RNA viral infections, such as COVID-19 and Influenza A/B, and therefore, we expect that SATORI will be established as a versatile platform for point-of-care testing of a wide range of infectious diseases, thus contributing to the prevention of future epidemics. This article is an extended version of the Japanese article published in the SEIBUTSU BUTSURI Vol. 63, p. 115-118 (2023).

Citing Articles

Portable wide-field femtoliter-chamber imaging system for point-of-care digital bioanalysis.

Iida T, Ando J, Yoshimura M, Makino A, Nakano M, Kogo Y iScience. 2024; 27(9):110868.

PMID: 39310765 PMC: 11416649. DOI: 10.1016/j.isci.2024.110868.


Rapid and Amplification-free Nucleic Acid Detection with DNA Substrate-Mediated Autocatalysis of CRISPR/Cas12a.

Zhou Z, Lau C, Wang J, Guo R, Tong S, Li J ACS Omega. 2024; 9(26):28866-28878.

PMID: 38973832 PMC: 11223203. DOI: 10.1021/acsomega.4c03413.


Exploring fluoropolymers for fabrication of femtoliter chamber arrays used in digital bioanalysis.

Ando J, Murai K, Mori M, Michiyuki T, Iida T, Makino A Sci Rep. 2024; 14(1):11442.

PMID: 38769440 PMC: 11106263. DOI: 10.1038/s41598-024-61726-8.


Toward versatile digital bioanalysis.

Ando J, Watanabe R Biomicrofluidics. 2023; 17(6):061303.

PMID: 38074951 PMC: 10708948. DOI: 10.1063/5.0174727.

References
1.
Noji H, Minagawa Y, Ueno H . Enzyme-based digital bioassay technology - key strategies and future perspectives. Lab Chip. 2022; 22(17):3092-3109. DOI: 10.1039/d2lc00223j. View

2.
Shinoda H, Taguchi Y, Nakagawa R, Makino A, Okazaki S, Nakano M . Amplification-free RNA detection with CRISPR-Cas13. Commun Biol. 2021; 4(1):476. PMC: 8055673. DOI: 10.1038/s42003-021-02001-8. View

3.
Gosert R, Naegele K, Hirsch H . Comparing the Cobas Liat Influenza A/B and respiratory syncytial virus assay with multiplex nucleic acid testing. J Med Virol. 2018; 91(4):582-587. PMC: 7166997. DOI: 10.1002/jmv.25344. View

4.
Broughton J, Deng X, Yu G, Fasching C, Servellita V, Singh J . CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020; 38(7):870-874. PMC: 9107629. DOI: 10.1038/s41587-020-0513-4. View

5.
Vogelstein B, Kinzler K . Digital PCR. Proc Natl Acad Sci U S A. 1999; 96(16):9236-41. PMC: 17763. DOI: 10.1073/pnas.96.16.9236. View